Cargando…
Multiple Genetic Analysis System-Based Antibiotic Susceptibility Testing in Helicobacter pylori and High Eradication Rate With Phenotypic Resistance-Guided Quadruple Therapy
Antibiotics resistance in Helicobacter pylori (H. pylori) is the major factor for eradication failure. Molecular tests including fluorescence in situ hybridization, PCR-restriction fragment length polymorphism, and dual priming oligonucleotide-PCR (DPO-PCR) play critical roles in the detection of an...
Autores principales: | Dong, Fangyuan, Ji, Danian, Huang, Renxiang, Zhang, Fan, Huang, Yiqin, Xiang, Ping, Kong, Mimi, Nan, Li, Zeng, Xianping, Wu, Yong, Bao, Zhijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058979/ https://www.ncbi.nlm.nih.gov/pubmed/26632710 http://dx.doi.org/10.1097/MD.0000000000002056 |
Ejemplares similares
-
Berberine containing quadruple therapy for initial Helicobacter pylori eradication: An open-label randomized phase IV trial
por: Zhang, Di, et al.
Publicado: (2017) -
A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: A single center experience
por: Abd-Elsalam, Sherief, et al.
Publicado: (2016) -
Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial
por: Su, Jing, et al.
Publicado: (2017) -
Optimal treatment duration of bismuth-containing quadruple therapy in Helicobacter pylori infection: A retrospective study
por: Kim, Ji Yoon, et al.
Publicado: (2023) -
Antibiotic susceptibility guided reuse of levofloxacin-based therapy in a penicillin-allergic patient for Helicobacter pylori infection: A case report
por: Kong, Siya, et al.
Publicado: (2021)